SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0000769993-15-000818
Filing Date
2015-07-10
Accepted
2015-07-10 14:14:26
Documents
1
Group Members
GS INVESTMENT STRATEGIES, LLC

Document Format Files

Seq Description Document Type Size
1 infinity2gsamgsis.txt SC 13G/A 20080
  Complete submission text file 0000769993-15-000818.txt   21908
Mailing Address 784 MEMORIAL DRIVE CAMBRIDGE MA 02139
Business Address 784 MEMORIAL DRIVE CAMBRIDGE MA 02139 6174531000
INFINITY PHARMACEUTICALS, INC. (Subject) CIK: 0001113148 (see all company filings)

IRS No.: 330655706 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-60943 | Film No.: 15983405
SIC: 2834 Pharmaceutical Preparations

Mailing Address 200 WEST STREET NEW YORK NY 10282
Business Address 200 WEST STREET C/O GOLDMAN SACHS & CO. NEW YORK NY 10282 312-655-4400
GOLDMAN SACHS ASSET MANAGEMENT, L.P. (Filed by) CIK: 0001229262 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE
Type: SC 13G/A